Detalhe da pesquisa
1.
Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT1D Receptor Activation via NO Pathway.
Int J Mol Sci
; 24(2)2023 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36674892
2.
Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.
Int J Mol Sci
; 23(10)2022 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628547
3.
Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
J Pharmacol Sci
; 147(1): 48-57, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34294372
4.
Dopamine D4 receptor subtype activation reduces the rat cardiac parasympathetic discharge.
Pflugers Arch
; 472(12): 1693-1703, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820344
5.
Fluoxetine oral treatment discloses 5-HT1D receptor as vagoinhibitor of the cardiac cholinergic neurotransmission in rat.
Can J Physiol Pharmacol
; 97(2): 90-98, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30462556
6.
Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow.
Can J Physiol Pharmacol
; 96(4): 328-336, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886249
7.
Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
J Cardiovasc Pharmacol
; 69(1): 13-22, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27676327
8.
5-HT modulates the rat mesenteric vasopressor outflow by 5-HT1D sympatholytic receptors.
Clin Exp Pharmacol Physiol
; 44(12): 1224-1231, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28771848
9.
Pharmacological evidence that 5-HT1D activation induces renal vasodilation by NO pathway in rats.
Clin Exp Pharmacol Physiol
; 42(6): 640-7, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25854421
10.
Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
Biomed Pharmacother
; 153: 113276, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35717784
11.
Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes.
Life Sci
; 293: 120335, 2022 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051421
12.
Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats.
Sci Rep
; 10(1): 19358, 2020 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33168874
13.
Hypertension exhibits 5-HT4 receptor as a modulator of sympathetic neurotransmission in the rat mesenteric vasculature.
Hypertens Res
; 42(5): 618-627, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30696976
14.
Pharmacological Evidence that Histamine H3 Receptors Mediate Histamine-Induced Inhibition of the Vagal Bradycardic Out-flow in Pithed Rats.
Basic Clin Pharmacol Toxicol
; 118(2): 113-21, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26301462
15.
Blocking 5-HT2 receptor restores cardiovascular disorders in type 1 experimental diabetes.
Sci Rep
; 6: 33979, 2016 Sep 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659784
16.
5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
Vascul Pharmacol
; 72: 172-80, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26003124
17.
Role of 5-HT7 receptors in the inhibition of the vasodepressor sensory CGRPergic outflow in pithed rats.
Vascul Pharmacol
; 63(1): 4-12, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25179247
18.
The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
Eur J Pharmacol
; 731: 80-7, 2014 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24675150
19.
Peripheral 5-HT1D and 5-HT7 serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
Eur J Pharmacol
; 714(1-3): 65-73, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23769743